Stockreport

BioAtla Announces Share Consolidation [TheStreet.com]

BioAtla, Inc.  (BCAB) 
PDF the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment o [Read more]